AngioDynamics
ANGO
169 hedge funds and large institutions have $597M invested in AngioDynamics in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 18 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 57
6% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 18
0.65% more ownership
Funds ownership: 97.04% → 97.69% (+0.65%)
1% more funds holding
Funds holding: 168 → 169 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $606M → $597M (-$9.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
+$15.4M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$6.67M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$6.26M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$4.61M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sentinel Asset Management
Montpelier,
Vermont
|
-$14.1M |
| 2 |
Millennium Management
New York
|
-$8.97M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$3.55M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.41M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$3.31M |
ANGO Hedge Fund Activity: Q4 2017 in Review
169 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q4 2017, worth a combined $597M — down 1.6% from $606M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ANGO positions and 18 closed out — a net gain of 1 holder — while 65 added to existing stakes and 57 trimmed.
The largest buyer was Fort Washington Investment Advisors, opening a new position worth an estimated $15.4M. The largest seller was Sentinel Asset Management, exiting entirely with an estimated $14.1M sold.
- 169 institutional investors held AngioDynamics (ANGO) as of Q4 2017, up from 168 in Q3 2017.
- Funds reported $597M of AngioDynamics stock for Q4 2017, down 1.6% quarter-over-quarter.
- 19 funds opened new AngioDynamics positions in Q4 2017 and 18 closed out, a net change of +1 holder.
- The largest AngioDynamics buyer in Q4 2017 was Fort Washington Investment Advisors, an estimated $15.4M added.
- The largest AngioDynamics seller in Q4 2017 was Sentinel Asset Management, an estimated $14.1M sold.
Based on aggregated 13F filings for Q4 2017.